kidney cancer

US: Breakthrough kidney cancer vaccine development
clinical trial results show that a vaccine against a factor called a neoantigen may help prevent the recurrence of kidney cancer.
Surgery may double the life expectancy for patients with kidney cancer
a new exciting medical discovery from kidney cancer patients receives the attention of international medical practitioners.